213 related articles for article (PubMed ID: 3092300)
1. Use of bacterial vaccines for prevention of pneumococcal and meningococcal disease in the day care setting.
Broome CV
Rev Infect Dis; 1986; 8(4):584-8. PubMed ID: 3092300
[TBL] [Abstract][Full Text] [Related]
2. Prevention of bacterial meningitis. Vaccines and chemoprophylaxis.
Lieberman JM; Greenberg DP; Ward JI
Infect Dis Clin North Am; 1990 Dec; 4(4):703-29. PubMed ID: 2126022
[TBL] [Abstract][Full Text] [Related]
3. Vaccine-preventable severe morbidity and mortality caused by meningococcus and pneumococcus: A population-based study in France.
Lorton F; Chalumeau M; Assathiany R; Martinot A; Bucchia M; Roué JM; Bourgoin P; Chantreuil J; Boussicault G; Gaillot T; Saulnier JP; Caillon J; Levy C; Cohen R; Gras-Le Guen C; Launay E
Paediatr Perinat Epidemiol; 2018 Sep; 32(5):442-447. PubMed ID: 30170336
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis of bacterial meningitis.
Peltola H
Infect Dis Clin North Am; 1999 Sep; 13(3):685-710, viii. PubMed ID: 10470562
[TBL] [Abstract][Full Text] [Related]
5. New vaccines for the prevention of pneumococcal infections.
Käyhty H; Eskola J
Emerg Infect Dis; 1996; 2(4):289-98. PubMed ID: 8969245
[TBL] [Abstract][Full Text] [Related]
6. [Suppurative bacterial meningitis and the outlook for specific prevention].
Demina AA; Deviatkina NP
Zh Mikrobiol Epidemiol Immunobiol; 1984 May; (5):3-10. PubMed ID: 6429984
[No Abstract] [Full Text] [Related]
7. Pneumococcal conjugate vaccine for young children.
Selman S; Hayes D; Perin LA; Hayes WS
Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
[TBL] [Abstract][Full Text] [Related]
8. Polysaccharide-based pneumococcal vaccines in the prevention of acute otitis media.
Eskola J
Vaccine; 2000 Dec; 19 Suppl 1():S78-82. PubMed ID: 11163468
[TBL] [Abstract][Full Text] [Related]
9. Vaccine Impact on Long-term Trends in Invasive Bacterial Disease in New Zealand Children.
Walls T; Cho V; Martin N; Williman J; Brunton C
Pediatr Infect Dis J; 2018 Oct; 37(10):1041-1047. PubMed ID: 30222697
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
Noronha CP; Struchiner CJ; Halloran ME
Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal conjugate vaccines in Asia and the Pacific. Singapore, 9-11 October 2000. Report of an Asia Pacific Board Advisory Meeting.
Vaccine; 2001 Sep; 19(32):4579-87. PubMed ID: 11729814
[No Abstract] [Full Text] [Related]
13. Recent developments in bacterial conjugate vaccines.
Goldblatt D
J Med Microbiol; 1998 Jul; 47(7):563-7. PubMed ID: 9839559
[TBL] [Abstract][Full Text] [Related]
14. Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study.
Martin NG; Sadarangani M; Pollard AJ; Goldacre MJ
Lancet Infect Dis; 2014 May; 14(5):397-405. PubMed ID: 24631222
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic approaches in children immunized with vaccine Prevenar].
Cohen R; Aujard Y; Bingen E; Boucherat M; Bourrillon A; Foucaud P; Francois M; Garnier JM; Guillot M; Ovetchkine P; Ployet MJ; Quinet B; Gaudelus J
Arch Pediatr; 2002 Jan; 9(1):4-6. PubMed ID: 11865548
[No Abstract] [Full Text] [Related]
16. Combination vaccine against invasive meningococcal B and pneumococcal infections: potential epidemiological and economic impact in the Netherlands.
Bos JM; Rümke HC; Welte R; Spanjaard L; van Alphen L; Postma MJ
Pharmacoeconomics; 2006; 24(2):141-53. PubMed ID: 16460135
[TBL] [Abstract][Full Text] [Related]
17. Selective primary health care: strategies for control of disease in the developing world. XIII. Acute bacterial meningitis.
Greenwood BM
Rev Infect Dis; 1984; 6(3):374-89. PubMed ID: 6429812
[TBL] [Abstract][Full Text] [Related]
18. [African aspects of vaccination in prevention of purulent meningitis].
Rey M
Ann Soc Belg Med Trop; 1980 Sep; 60(3):237-52. PubMed ID: 6788000
[No Abstract] [Full Text] [Related]
19. Prospects for the prevention of meningococcal disease: special reference to group B.
Frasch CE
Vaccine; 1987 Mar; 5(1):3-4. PubMed ID: 3107234
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: immunogenicity and efficacy in experimental pneumococcal otitis media.
Giebink GS; Koskela M; Vella PP; Harris M; Le CT
J Infect Dis; 1993 Feb; 167(2):347-55. PubMed ID: 8421168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
